Search Items: BREAST NEOPLASMS - THERAPY , . hits: 35
Minichsdorfer, C; Fuereder, T; Leutner, M; Singer, CF; Kacerovsky-Strobl, S; Egle, D; Greil, R; Balic, M; Fitzal, F; Pfeiler, G; Frantal, S; Bartsch, R; Gnant, M
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18.
ESMO Open. 2022; 7(2):100426
Doi: 10.1016/j.esmoop.2022.100426
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tsibulak, I; Reiser, E; Bogner, G; Petru, E; Hell-Teutsch, J; Reinthaller, A; Weirather, C; Weiss, T; Bozsa, S; Puschacher, B; Hall, M; Hittler, D; Hrauda, K; Thell, E; Clauss, S; Pozniak, J; Alicke, S; Gangl, D; Gamperl, G; Ebner, C; Knoll, K; Leitner, K; Schilcher, A; Schinnerl, M; Sigl, V; Singer, C; Aigmüller, T; Hofstätter, B; Marth, C
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
Int J Gynecol Cancer. 2020; 30(11):1667-1671
Doi: 10.1136/ijgc-2020-001975
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Strell, C; Paulsson, J; Jin, SB; Tobin, NP; Mezheyeuski, A; Roswall, P; Mutgan, C; Mitsios, N; Johansson, H; Wickberg, SM; Svedlund, J; Nilsson, M; Hall, P; Mulder, J; Radisky, DC; Pietras, K; Bergh, J; Lendahl, U; Wärnberg, F; Östman, A
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
J Natl Cancer Inst. 2019; 111(9):983-995
Doi: 10.1093/jnci/djy234
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bayraktar, R; Pichler, M; Kanlikilicer, P; Ivan, C; Bayraktar, E; Kahraman, N; Aslan, B; Oguztuzun, S; Ulasli, M; Arslan, A; Calin, G; Lopez-Berestein, G; Ozpolat, B
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Oncotarget. 2017; 8(7): 11641-11658.
Doi: 10.18632/oncotarget.14264
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Biganzoli, L; Marotti, L; Hart, CD; Cataliotti, L; Cutuli, B; Kühn, T; Mansel, RE; Ponti, A; Poortmans, P; Regitnig, P; van der Hage, JA; Wengström, Y; Rosselli Del Turco, M
Quality indicators in breast cancer care: An update from the EUSOMA working group.
Eur J Cancer. 2017; 86(9):59-81
Doi: 10.1016/j.ejca.2017.08.017
Web of Science
PubMed
FullText
FullText_MUG
Bjelic-Radisic, V; Dorfer, M; Tamussino, K; Greimel, E
Patients' view of routine follow-up after breast cancer treatment.
Wien Klin Wochenschr. 2017; 129(21-22):810-815
Doi: 10.1007/s00508-017-1278-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seiler, A; Büel-Drabe, N; Jenewein, J
Praxis (Bern 1994). 2017; 106(3):135-142
Doi: 10.1024/1661-8157/a002595
PubMed
FullText
FullText_MUG
Ghislain, I; Zikos, E; Coens, C; Quinten, C; Balta, V; Tryfonidis, K; Piccart, M; Zardavas, D; Nagele, E; Bjelic-Radisic, V; Cardoso, F; Sprangers, MAG; Velikova, G; Bottomley, A; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; Breast Cancer Group; EORTC Headquarters
Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials.
Lancet Oncol. 2016; 17(7):e294-e304-e294-e304
Doi: 10.1016/S1470-2045(16)30099-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dahlhaus, A; Semlitsch, T; Jeitler, K; Horvath, K; Siebenhofer, A
Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
Fam Pract. 2015; 32(5):483-491
Doi: 10.1093/fampra/cmv053
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Br J Cancer. 2015; 112(8):1405-1410
Doi: 10.1038/bjc.2015.98
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jacobsen, PB; Lee, JH; Fulp, W; Siegel, EM; Shibata, D; Laronga, C; Gray, J; Tanvetyanon, T; Schreiber, F; Brown, R; Levine, R; Cartwright, T; Abesada-Terk, G; Kim, G; Alemany, C; Faig, D; Sharp, P; Markham, MJ; Malafa, M
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval.
J Oncol Pract. 2015; 11(1):e103-e109
Doi: 10.1200/JOP.2014.001525
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Provenzano, E; Bossuyt, V; Viale, G; Cameron, D; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Boughey, J; Curigliano, G; Dixon, JM; Esserman, L; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Symmans, WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
MODERN PATHOL. 2015; 28(9): 1185-1201.
Doi: 10.1038/modpathol.2015.74
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
van Dam, PA; Tomatis, M; Marotti, L; Heil, J; Wilson, R; Rosselli Del Turco, M; Mayr, C; Costa, A; Danei, M; Denk, A; Emons, G; Friedrichs, K; Harbeck, N; Kiechle, M; Koheler, U; Kuemmel, S; Maass, N; Marth, C; Prové, A; Kimmig, R; Rageth, C; Regolo, L; Salehi, L; Sarlos, D; Singer, C; Sohn, C; Staelens, G; Tinterri, C; Ponti, A; eusomaDB Working Group:; eusomaDB Working Group
The effect of EUSOMA certification on quality of breast cancer care.
Eur J Surg Oncol. 2015; 41(10):1423-1429
Doi: 10.1016/j.ejso.2015.06.006
Web of Science
PubMed
FullText
FullText_MUG
Regierer, AC; Wolters, R; Ufen, MP; Weigel, A; Novopashenny, I; Köhne, CH; Samonigg, H; Eucker, J; Possinger, K; Wischnewsky, MB
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.
Ann Oncol. 2014; 25(3):633-638
Doi: 10.1093/annonc/mdt539
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Stöger, H
Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
Dtsch Med Wochenschr. 2013; 138(41):2096-2096
Doi: 10.1055/s-0033-1349531
Web of Science
PubMed
FullText
FullText_MUG
Balic, M; Lin, H; Williams, A; Datar, RH; Cote, RJ
Progress in circulating tumor cell capture and analysis: implications for cancer management.
Expert Rev Mol Diagn. 2012; 12(3):303-312
Doi: 10.1586/erm.12.12
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Luschin, G; Habersack, M; Gerlich, IA
Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debate.
BMC MED RES METHODOL. 2012; 12(5): 25-25.
Doi: 10.1186/1471-2288-12-25
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Partl, R; Richtig, E; Kapp, KS
Calling attention to radiation recall reactions. Simultaneous occurrence of a Recall Dermatitis after CMF application in two separate sites irradiated 10 years apart.
Acta Oncol. 2012; 51(6):809-811
Doi: 10.3109/0284186X.2011.639799
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pristauz, G; Geigl, JB; Petru, E
BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer.
Wien Med Wochenschr. 2010; 160(7-8): 158-162.
Doi: 10.1007/s10354-010-0772-7
PubMed
FullText
FullText_MUG
Sardanelli, F; Boetes, C; Borisch, B; Decker, T; Federico, M; Gilbert, FJ; Helbich, T; Heywang-Kobrunner, SH; Kaiser, WA; Kerin, MJ; Mansel, RE; Marotti, L; Martincich, L; Mauriac, L; Meijers-Heijboer, H; Orecchia, R; Panizza, P; Ponti, A; Purushotham, AD; Regitnig, P; Del Turco, MR; Thibault, F; Wilson, R
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
EUR J CANCER. 2010; 46(8): 1296-1316.
Doi: 10.1016/j.ejca.2010.02.015
Web of Science
PubMed
FullText
FullText_MUG
Gnant, M; Dubsky, P; Fitzal, F; Blaha, P; Schoppmann, S; Steger, G; Marth, C; Samonigg, H; Hüttner, K; Fohler, H; Ruecklinger, E; Jakesz, R; Greil, R; Austrian Breast and Colorectal Cancer Study Group
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Clin Breast Cancer. 2009; 9 Suppl 1: S18-S27.
Doi: 10.3816/CBC.2009.s.002
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Puchinger, M; Meinitzer, A; Stettin, M; Rehak, PH
Psychological and systemic stress reactions of patients during hyperthermia treatments.
Int J Hyperthermia. 2009; 25(6): 488-497.
Doi: 10.1080/02656730903039613
Web of Science
PubMed
FullText
FullText_MUG
Fink, D; Lang, U; Kimmig, R
Fundamental advances in the adjuvant systemic therapy of breast cancer
Gynakol Geburtshilfliche Rundsch. 2008; 48(3):111-112
Doi: 10.1159/000127391
PubMed
FullText
FullText_MUG
Kimmig, R; Fink, D; Lang, U
Physical integrity versus oncological safety: synthesis of important aspects in the treatment of breast cancer
Gynakol Geburtshilfliche Rundsch. 2008; 48(2):55-55
Doi: 10.1159/000118931
PubMed
FullText
FullText_MUG
Mazouni, C; Peintinger, F; Wan-Kau, S; Andre, F; Gonzalez-Angulo, AM; Symmans, WF; Meric-Bernstam, F; Valero, V; Hortobagyi, GN; Pusztai, L
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
J Clin Oncol. 2007; 25(19): 2650-2655.
Doi: 10.1200/JCO.2006.08.2271
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Andritsch, E; Goldzweig, G; Samonigg, H; Uziely, B; Ever-Hadani, P; Hoffman, G; Krenn, G; Baider, L
Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study.
SUPPORT CARE CANCER. 2004; 12(1): 10-18.
Doi: 10.1007/s00520-003-0531-z
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Baider, L; Andritsch, E; Goldzweig, G; Uziely, B; Ever-Hadani, P; Hofman, G; Krenn, G; Samonigg, H
Changes in psychological distress of women with breast cancer in long-term remission and their husbands.
PSYCHOSOMATICS. 2004; 45(1): 58-68.
Doi: 10.1176/appi.psy.45.1.58
Web of Science
PubMed
FullText
FullText_MUG
Stranzl, H; Peintinger, F; Ofner, P; Prettenhofer, U; Mayer, R; Hackl, A
Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Strahlenther Onkol. 2004; 180(10):623-628
Doi: 10.1007/s00066-004-1241-2
Web of Science
PubMed
FullText
FullText_MUG
Weissenberger, C; Jonassen, S; Beranek-Chiu, J; Neumann, M; Muller, D; Bartelt, S; Schulz, S; Monting, JS; Henne, K; Gitsch, G; Witucki, G
Breast cancer: patient information needs reflected in English and German web sites.
Br J Cancer. 2004; 91(8):1482-1487
Doi: 10.1038/sj.bjc.6602168
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Greimel, E; Thiel, I; Peintinger, F; Cegnar, I; Pongratz, E
Prospective assessment of quality of life of female cancer patients.
Gynecol Oncol. 2002; 85(1):140-147
Doi: 10.1006/gyno.2002.6586
Web of Science
PubMed
FullText
FullText_MUG
Helbich, TH; Fuchsjäger, MH
Mammography referral center combined with breast cancer center.
Wien Med Wochenschr Suppl. 2002; 14(113):82-84
PubMed
Dettke, M; Greinix, HT; Kalhs, P; Kührer, I; Worel, N; Höcker, P
Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest.
Transfusion. 2001; 41(5):681-686
Doi: 10.1046/j.1537-2995.2001.41050681.x
Web of Science
PubMed
FullText
FullText_MUG
Greinix, H
Place of high-dose therapy in breast cancer. Austrotransplant consensus conference 1999].
Wien Klin Wochenschr. 2000; 112(13):601-603
Web of Science
PubMed
Steger, GG; Locker, G; Rainer, H; Mader, RM; Sieder, AE; Gnant, MF; Aberer, W; Jakesz, R
Cutaneous reactions to GM-CSF in inflammatory breast cancer.
N Engl J Med. 1992; 327(4):286-286
Doi: 10.1056/NEJM199207233270418
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Beaufort, F; Drofenik, M; Pleyer, K
Evaluation of drugs with questionable effectiveness and so-called natural preparations in oncology by patients. Results of a survey
Wien Med Wochenschr. 1988; 138(4):85-91
Web of Science
PubMed